Biotech Growth Trust (The)'s quarterly market cap
declined
from Sep. 2022 (£398.42 Mil) to Mar. 2023 (£303.31 Mil) and
declined
from Mar. 2023 (£303.31 Mil) to Sep. 2023 (£278.40 Mil).
Biotech Growth Trust (The)'s annual market cap
declined
from Mar. 2021 (£593.00 Mil) to Mar. 2022 (£369.61 Mil) and
declined
from Mar. 2022 (£369.61 Mil) to Mar. 2023 (£303.31 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biotech Growth Trust (The)'s Enterprise Value for Today is £324.67 Mil.
Biotech Growth Trust (The) Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biotech Growth Trust (The)'s Market Cap
For the Asset Management subindustry, Biotech Growth Trust (The)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotech Growth Trust (The)'s Market Cap Distribution in the Asset Management Industry
For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Market Cap distribution charts can be found below:
* The bar in red indicates where Biotech Growth Trust (The)'s Market Cap falls into.
Biotech Growth Trust (The) Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotech Growth Trust (The) (LSE:BIOG) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Biotech Growth Trust (The) Market Cap Related Terms
Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Biotech Growth Trust (The) (LSE:BIOG) Business Description
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:BIOG has been successfully added to your 